BJDX - Why BlueJay Diagnostics Stock Is Falling | Benzinga
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) shares are trading lower Thursday after the company announced the pricing of a $3.5 million public offering.
The Details:
BlueJay Diagnostics announced the public offering of 2,692,308 shares at $1.30 per share. The gross proceeds from the offering are expected to be approximately $3.5 million, and BlueJay Diagnostics intends to use the proceeds to fund ...